Skip to content

Limitless Pharma

Active
Private limited companyfounded 2023active for 3 yearsMerksemsesteenweg 196, 2100 Antwerpen, BelgiumKBO/BCE: BE 0802.144.864
Summary

The computed 12-month bankruptcy probability of Limitless Pharma is 4.1% (elevated). The 2025 annual accounts show negative equity (-€22,918) and a net result of -€18,605. Its solvency ranks better than 9% of 21,983 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

History

Limitless Pharma was incorporated on 26 May 2023 as a private limited company.1 The company has filed 2 sets of annual accounts, the latest for financial year 2025.2

  1. 1KBO (Crossroads Bank for Enterprises)
  2. 2National Bank, annual accounts 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-09
NBB filing Annual accounts filed
financial year 2025 · micro format · 60 days late
20-03
Gazette deed Resignation: Libert Philip (director)
2 facts ▸
  • General meeting, 08-12-2025
  • Director resignation, Libert Philip (director)
2025
23-07
NBB filing Annual accounts filed
financial year 2024 · micro format
Gazette deedNBB filing
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.